Gremlin is a member of the bone morphogenetic protein (BMP) antagonist family and its antagonistic effect is likely through direct binding to BMP proteins. As an antagonist of BMP, Gremlin plays a role in regulating organogenesis, body patterning and tissue differentiation. Recent studies have shown a deregulation of Gremlin in several types of human cancers. However, the role of Gremlin in human malignant mesothelioma (MM) is still unknown. In this study, we investigated the expression of Gremlin in human MM. We found that Gremlin mRNA and protein were both overexpressed in the majority of primary MM tissue samples that we examined. We also observed high level expression of the Gremlin gene in 4 of the 6 MM cell lines. Consistently, we found that the Gremlin promoter activity was significantly elevated in those MM cell lines expressing the Gremlin gene. On the other hand, no activity of the Gremlin promoter was detected in the two MM cell lines lacking Gremlin expression. Moreover, to examine the functional significance of the Gremlin overexpression in MM, we used shRNA to knock down Gremlin expression in MM cell lines expressing Gremlin and found that inhibition of Gremlin expression significantly suppressed proliferation of those MM cells. Taken together, our results suggest that the BMP antagonist Gremlin is overexpressed in MM and that aberrant activation of Gremlin may play a critical role in the tumorigenesis of human MM.
Introduction
Malignant mesothelioma (MM) is associated with asbestos and it is characterized by rapidly progressive and diffuse growth, late metastases, and very poor prognosis (1, 2) . The disease is of rapid progression and most patients die within 12-15 months of the first symptoms if untreated (1, 3) . It is critical to improve understanding of the molecular mechanism of MM in order to find much needed effective new therapies for the treatment of this disease. Gremlin encodes a member of the Dan family of secreted glycosylated proteins [also known as Down-regulated by v-mos (Drm)] (4, 5) . Gremlin has been reported to be an antagonist of the bone morphogenetic protein (BMP) family, likely through direct binding to BMP proteins (6) . BMP family proteins are members of the transforming growth factor-β (TGF-β) superfamily and critical mediators of early embryonic patterning involved in skeletal development and bone formation (7, 8) . Inactivation of the BMP genes has been reported in several cancer types, including lung, breast, prostate and colon cancers, lymphomas and mesotheliomas (9) (10) (11) (12) (13) (14) (15) , suggesting the importance of BMPs in tumorigenesis of these cancers. As an antagonist of BMP proteins, Gremlin also plays important roles during early development (16) (17) (18) (19) , as well as tumorigenesis of several types of cancers (20) (21) (22) (23) (24) (25) . However, the role of Gremlin in ΜΜ has not been reported before and still remains unknown. Therefore, in this study, our goal was to examine the expression of the Gremlin gene in human MM cell lines as well as primary tissue samples, and to investigate the possible functional roles that Gremlin plays in MM. The fluorescence intensity of amplicons was analyzed during the extension step of the cycling. 18S rRNA was used as an internal control. The primers and probes were synthesized at Sangon Corp. The sequences of the primers and probes were: for Gremlin, forward, 5'-ATCAACCGCTTCTGTTACGG-3'; reverse, 5'-CGATGGATATGCAACGACAC-3'; probe, 5'-GTCACAC TCAACTGCCCTGA-3'; for 18S rRNA, forward, 5'-ACATCC AAGGAAGGCAGCAG-3'; reverse, 5'-TTCGTCACTACCT CCCCGG-3'; probe, 5'-CGCGCAAATTACCCACTCCCGA-3' . The 2 -∆∆Ct method was used to calculate relative expression levels of Gremlin by normalizing to a normal control sample made by mixing an equal amount RNA of the eight matched normal pleural tissues from MM patients (26) .
Materials and methods

Cell
Western blotting. Whole cell lysates of MM primary tissue cultures were obtained using CytoBuster protein extraction reagent (Novagen, Madison, WI, USA). Samples containing 40 µg of proteins were electrophoresed on a 10% SDS-polya crylamide gel. A standard protocol for Western blotting was used. Antigen-antibody complexes were detected by the ECL blotting analysis system (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Anti-Gremlin polyclonal and β-actin monoclonal antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Cloning and construction of the Gremlin promoter region.
PCR was used to amplify the Gremlin promoter region. Sense and antisense primers were chosen based on the 5' flanking genomic sequence upstream the Gremlin gene (the first nucleotide of the first exon of the Gremlin gene is defined as +1). Two adaptors, 5'-CAGGAGATCT-3' (BglII site underlined) and Table I . Primer sequences for cloning the Gremlin promoter-luciferase constructs.
Construct
Primer sequences Size (bp) 5'-CAGGAAGCTT-3' (HindIII site underlined) were added to each sense and antisense primers, respectively in order to clone the promoter fragments into a luciferase reporter vector pGL3Basic (Promega) for functional analysis. The primers used to generate different constructs are listed in Table I . The relative positions of all amplicons are also illustrated in Fig. 3 . Forty cycles of amplification were performed using human genomic DNA isolated from cultured 293T cells as the template. The PCR products were then extracted from the agarose gel using the TIANgel Midi Purification kit (Tiangen), digested with BglII and HindIII (Takara), and subcloned into the BglII (5') and HindIII (3') sites of the pGL3Basic vector. GLprimer2 (Promega) was used as a sequencing primer to ensure the correct orientation and sequence of each construct at Shanghai Invitrogen Biotechnology Co., Ltd.
Transfection and promoter activity analysis. Cells (1x10 4 ) were plated in 12-well plates one day before transfection. When cells reached 60-80% confluence, 2.5 µg of each construct were co-transfected with 0.05 µg pRL-TK vector (Promega), which contains Renilla luciferase as an internal control for the transfection efficiency. Vigofect (Vigorous, Beijing, China) was used to mediate all transfections according to the manufacturer's protocol. The transfected cells were cultured for an additional day before being lysed for luciferase assays. Briefly, cells were lysed in passive lysis buffer and then firefly and Renilla luciferase activities of each well were measured using the Dual-Luciferase Assay system (Promega).
Firefly luciferase activities were all normalized to Renilla luciferase activities in the same well and were expressed relative to the basal activity of the empty pGL3Basic vector, which was set to unity. The data represent the mean values ± SD. All measurements in each experiment were performed in triplicate and at least three independent experiments were repeated to ensure consistency.
Gremlin shRNA transfection and cell proliferation assay. Gremlin shRNA plasmid (the targeted Gremlin sequence was: 5'-CCGCTTCTGTTACGGCCAGTGCAACTCTT-3' , cat. no. TR312620) was purchased from Origene (Rockville, MD, USA). The control scrambled shRNA (Cat. no. TR30012) was also from Origene. Vigofect was used to mediate all transfections according to the manufacturer's protocol. Cell proliferation was determined by the CellTiter 96 AQueous Non-Radiotive Cell Proliferation Assay kit (Promega) according to the manufacturer's protocol. Briefly, transfected cell lines were plated into 96-well tissue culture plates at 5x10 2 cells/well. The MTS solution was added to the medium and incubated for 1.5 h at 37˚C at different time points post cell plating. The absorbance at 490 nm was measured using the microplate reader model 680 (Bio-Rad, Hercules, CA, USA).
Statistical analysis.
The data presented represent the means ± SD. Comparisons were conducted using the unpaired t-test. A P<0.05 was considered to be significant. 
Results
Expression of Gremlin is up-regulated in primary MM tissue samples.
To investigate the possible role of Gremlin in MM, we first examined the expression level of the Gremlin gene in primary MM tissue samples (Fig. 1) . We found that the mRNA level of the Gremlin gene was significantly up-regulated in 7 of the 8 MM tissue samples that we examined when compared to their paired normal tissue samples from same patients (Fig. 1A) . Next, we performed Western blotting on the same 8 MM tissue samples and we found that the Gremlin protein expression was also up-regulated in the same 7 MM tissue samples compared to their paired normal tissues, consistent with their mRNA expression levels (Fig. 1B) . We also examined additional 20 primary MM tissue samples by using real-time RT-PCR and found that 85% (17/20) showed the up-regulated Gremlin mRNA expression (Fig. 1C) (P<0.05) . Taken together, these results suggest that the Gremlin is overexpressed in human MM.
Expression of Gremlin in MM cell lines.
To confirm our observation in MM tissue samples, we next examined the Gremlin expression in MM cell lines (Fig. 2) . Of the 6 MM cell lines examined, 4 cell lines (H920, H2450, REN and H2052) showed high level of the Gremlin mRNA expression. On the other hand, little or no mRNA expression of Gremlin was found in cell lines H28 and MS-1.
Activity of the Gremlin promoter in MM cell lines.
In order to investigate the transcriptional regulation of the Gremlin expression in MM, we seek to clone and analyze the Gremlin promoter. A BLAST search was first performed using the Gremlin coding sequence as a probe against the human genomic database at the UCSC server (http://genome.ucsc. edu/) to identify the 5' flanking region of the Gremlin gene (Fig. 3A) . We confirmed classical features of a promoter in this 5' flanking region using a promoter search program (http:// www.genomatix.de/). Several important putative binding sites of transcription factors such as Smad3, Gli, TCF/LEF-1, TTF-1 and STAT were observed in this region (Fig. 3A) . These transcription factors themselves have been shown to play important oncogenic roles in tumorigenesis of many cancer types, including MM (27) (28) (29) (30) (31) . We next cloned several fragments of the Gremlin promoter region into a promoterless luciferase expression vector pGL3Basic and transfected 293T cells with these constructs to examine luciferase activities (Fig. 3B) . We confirmed that this region had significant promoter activity compared to the empty vector control. Next, we transfected the fragment of the Gremlin promoter construct with the highest activity in 293T cells (construct no. 6) into different MM cell lines and examined the luciferase activity after 24 h (Fig. 4) . We found that this promoter construct displayed significantly high luciferase activities (P<0.04) in the 4 MM cell lines (H920, H2450, REN, H2052) which strongly expressed Gremlin mRNA (Figs. 2 and 4) . Consistently, no Gremlin promoter activity was observed in MS-1 and H28 that lacked endo genous Gremlin expression (Figs. 2 and 4) .
shRNA knock-down of Gremlin mRNA expression suppressed proliferation of MM cell lines. To study the functional role of the Gremlin overexpression in MM, we used shRNA to knock down Gremlin expression in the MM cell lines H290 and H2450 that expressed high levels of Gremlin. We confirmed the silencing of Gremlin expression after Gremlin shRNA treatment (100 nM for 48 h) by semi-quantitative RT-PCR analysis (Fig. 5A) . We found that knock-down of Gremlin expression led to significant proliferative suppression in both cell lines (Fig. 5B) (P<0.002) , suggesting that Gremlin might be necessary for proliferation of these MM cells. 
Discussion
Progression of malignant mesothelioma (MM) is rapid and if untreated, most patients die within 12-15 months of the first symptoms (1, 3) . However, no current chemotherapy regimen for mesothelioma has yet proven wholly curative. Clinical trials show objective response rates of 41-48%, and the therapies themselves are still controversial (32) (33) (34) (35) . Recently, molecular target therapies such as imanitib and gefinitib have also been studied in MM patients. However, these drugs do not appear to be effective against MM according to early studies (36, 37) . Therefore, it is critical to improve our understanding of the mechanisms of MM in order to find much needed effective new therapies for the treatment of this disease.
It has been reported that the BMP gene family is inactivated in a number of cancer types, including lung cancer, breast cancer, prostate cancer, colon cancer, lymphoma, and mesothelioma and BMP proteins are of great importance in tumorigenesis of these cancers (9) (10) (11) (12) (13) (14) (15) . As an antagonist of BMP proteins likely through direct binding to BMP proteins (6), Gremlin has recently been shown to be deregulated during tumorigenesis of several types of cancers such as lung, breast, ovarian and cervical cancers (20) (21) (22) (23) (24) (25) . However, the role of Gremlin in malignant mesothelioma has not been studied before and still remains unknown. In this study, we reported, for the first time, that Gremlin was overexpressed in the majority of primary human MM tissue samples and cell lines examined. As a confirmation study of the Gremlin overexpression in MM, we cloned the Gremlin promoter region and examined its activity in MM cell lines. Consistently, we found that these MM cell lines with high level of Gremlin expression displayed significantly elevated Gremlin promoter activity and that these MM cell lines lacking Gremlin expression did not show Gremlin promoter activity. Although further investigation with larger number of MM tissue samples will be needed, our findings strongly suggest that increased expression of the Gremlin gene may be associated with tumorigenesis of human MM.
Moreover, to examine the functional significance of the Gremlin overexpression in MM, we used shRNA to knockdown the Gremlin expression in MM cell lines expressing Gremlin and found that inhibition of the Gremlin expression significantly suppressed proliferation of those MM cells. A recent study by Kimura et al (15) reported aberrant methylation silencing of BMP genes BMP3b and BMP6 in human MM, suggesting that these BMP genes may have a role as tumor suppressor genes in MM. Taken together, our results are consistent with these previous findings in MM and support the importance of aberration of BMP signaling in tumorigenesis of human MM. While further studies are needed to characterize cellular functions and regulatory mechanisms, such as the interaction between Gremlin and BMP family members and downstream signaling events, the BMP antagonist Gremlin seems to be a candidate oncoprotein in the development of human MM, and could be a good target for developing diagnostic and therapeutic strategies against human MM.
In summary, we have shown that Gremlin is overexpressed in human MM cell lines and tissue samples. Overexpression of Gremlin may be important for the aberrant BMP signaling pathway in MM and for the consequent proliferation of MM cells. This is the first demonstration of the importance of Gremlin as a putative oncogene in human mesothelioma. Our results support Gremlin as a therapeutic target for this highly aggressive cancer.
